CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 140.00
+1.00 (0.72%)
Jul 24, 2026, 5:29 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.34 billion as of July 24, 2026. Its market cap has decreased by -21.26% in one year.
Market Cap
3.34B
Enterprise Value
3.22B
Revenue
739.15M
Ranking
n/a
PE Ratio
25.87
Stock Price
140.00
ChartMarket Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.34B, an increase of 797.42%. That is a compound annual growth rate of 12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.34B | -10.94% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elekta AB | 17.96B |
| Nolato AB | 12.90B |
| Vitrolife AB | 11.54B |
| MedCap AB | 8.33B |
| Xvivo Perfusion AB | 7.41B |
| C-Rad AB | 1.25B |
| Paxman AB | 1.09B |
| Devyser Diagnostics AB | 1.05B |